IQVIA Holdings | IQV - PE Price to Earnings


IQVIA Holdings reported 26.59 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Accenture 15.28 3.18 Dec/2025
Agilent 25.04 2.13 Dec/2025
Bruker 81.36 60.11 Dec/2025
Cardinal Health 24.53 4.66 Dec/2025
Celltrion 50.09 23.24 Sep/2025
Charles River Laboratories 43.58 0.86 Dec/2025
Cigna 10.56 0.76 Dec/2025
Cognizant Technology Solutions 15.49 2.63 Dec/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
CVS Health 14.39 2.15 Dec/2025
Danaher 29.29 10.39 Mar/2026
Dentsply International 29.99 15.81 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Elevance Health 12.4 0.98 Mar/2026
Humana 26.05 7.23 Dec/2025
IBM 24.1 5.96 Mar/2026
Illumina 30.38 15.53 Dec/2025
Infosys 24.15 2.67 Dec/2025
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Laboratory Of America 20.86 10.79 Dec/2025
Malin Corporation 11.81 0.72 Jun/2023
McKesson 23.85 0.07 Dec/2025
Mettler Toledo International 32.41 2.38 Dec/2025
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 17.41 29.74 Dec/2025
Publicis 12.84 0.17 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Quest Diagnostics 22.4 2.63 Mar/2026
Revvity 49.87 16.58 Dec/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Thermo Fisher Scientific 27.71 3.29 Mar/2026
Tilray 11.56 80.19 Sep/2025
UnitedHealth 15.29 4.5 Mar/2026
Veeva Systems 36.24 18.53 Dec/2025
Veradigm 11.15 4.63 Sep/2022
Waters 35.29 8.46 Dec/2025
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 49.04 4.33 Sep/2025